Granules Biocause Pharmaceuticals Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 2

Granules Biocause Pharmaceuticals General Information

Description

Manufacturer of ibuprofen in Jingmen, China. The company engages in manufacturing, processing and selling active pharmaceutical ingredients such analgesic and anti-inflammatory drugs in Jingmen, China.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Yangwan Road, 122
  • Jingmen, Hubei
  • China
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • Yangwan Road, 122
  • Jingmen, Hubei
  • China

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Granules Biocause Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Granules Biocause Pharmaceuticals‘s full profile, request access.

Request a free trial

Granules Biocause Pharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Granules Biocause Pharmaceuticals‘s full profile, request access.

Request a free trial

Granules Biocause Pharmaceuticals FAQs

  • When was Granules Biocause Pharmaceuticals founded?

    Granules Biocause Pharmaceuticals was founded in 2007.

  • Where is Granules Biocause Pharmaceuticals headquartered?

    Granules Biocause Pharmaceuticals is headquartered in Jingmen, China.

  • What industry is Granules Biocause Pharmaceuticals in?

    Granules Biocause Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Granules Biocause Pharmaceuticals a private or public company?

    Granules Biocause Pharmaceuticals is a Private company.

  • What is Granules Biocause Pharmaceuticals’s current revenue?

    The current revenue for Granules Biocause Pharmaceuticals is .

  • Who are Granules Biocause Pharmaceuticals’s investors?

    Granules India has invested in Granules Biocause Pharmaceuticals.

  • When was Granules Biocause Pharmaceuticals acquired?

    Granules Biocause Pharmaceuticals was acquired on 04-Feb-2020.

  • Who acquired Granules Biocause Pharmaceuticals?

    Granules Biocause Pharmaceuticals was acquired by Hubei Biocause Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process